Market Snapshot

BSE Sensex: 81332.72 1.62%
BSE 500: 36795.89 1.65%
BSE 200: 11475.13 1.74%
BSE 100: 26248.18 1.76%
BSE MidCap: 47706.67 2.12%
BSE SmallCap: 54294.35 1.00%
BSE BANKEX: 58638.77 0.86%
BSE IT: 41836.85 2.15%
Nifty 50: 24834.85 1.76%
Nifty 500: 23292.05 1.64%
Nifty 200: 14039.2 1.73%
Nifty 100: 25841.9 1.71%
Nifty Midcap 100: 57768.1 1.81%
Nifty Small 100: 18854 0.97%
Nifty IT: 40977.35 2.30%
Nifty PSU Bank: 7270.65 1.66%

News:

BHEL receives LOI for Rs 10,00...
Gujarat Themis Q1 PAT falls ov...
Power Grid Q1 PAT rises 3% YoY...
IndusInd Bank PAT rises to Rs ...
Cipla spurts as Q1 PAT rises 1...

Concord Drugs Ltd Share Price – BSE
Pharmaceuticals, Small Cap

Invest

26 Jul 2024 | 03:59 PM

38.24

-0.15 (-0.39%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

28.84%

Return (1Y)

Beaten BSE Sensex by 6.92%
More Volatile

3.75%

Standard Deviation (1Y)

Higher than BSE Sensex by 2.95%
Not so consistent

6/12

Months

underperformed BSE Sensex
AxisDirect View

No View

52 Week High-Low

62

28

News & Announcements

Concord Drugs reports consolidated net loss of Rs 0.34 crore in the March 2024 quarter

57 days ago

Concord Drugs postpones board meeting
63 days ago

Concord Drugs postpones board meeting

25 - May - 2024 12:00 AM | 63 days ago

Concord Drugs has postponed the meeting of the Board of Directors which was scheduled to be held on 25 May 2024. The meeting will now be held on 30 May 2024.
Powered by Capital Market - Live News
Concord Drugs declare Quarterly Result
72 days ago

Concord Drugs declare Quarterly Result

16 - May - 2024 12:00 AM | 72 days ago

Concord Drugs will hold a meeting of the Board of Directors of the Company on 25 May 2024
Powered by Capital Market - Live News
Concord Drugs reports consolidated net loss of Rs 0.24 crore in the December 2023 quarter
164 days ago

Concord Drugs reports consolidated net loss of Rs 0.24 crore in the December 2023 quarter

14 - Feb - 2024 12:00 AM | 164 days ago

Net loss of Concord Drugs reported to Rs 0.24 crore in the quarter ended December 2023 as against net profit of Rs 0.45 crore during the previous quarter ended December 2022. Sales declined 5.54% to Rs 12.78 crore in the quarter ended December 2023 as against Rs 13.53 crore during the previous quarter ended December 2022.
Particulars Quarter Ended
Dec. 2023 Dec. 2022 % Var.
Sales 12.78 13.53 -6
OPM % 4.93 10.64 -
PBDT 0.13 1.00 -87
PBT -0.26 0.62 PL
NP -0.24 0.45 PL
Powered by Capital Market - Live News

Price vs Volume

1D
5D
1M
3M
1Y
3Y
5Y
MAX

Stock Trivia

Promoter shareholding in Concord Drugs Ltd has increased by 6.29% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

×

Online trading for clients based in USA and Canada is restricted. You can continue placing orders through mapped dealers offline

OK

vV5.0.0.6-60